Clinical Cancer Drugs,volume 1,issue 2  (05-2014)

Period of time： 2014年2期

Publisher： Bentham Science Publishers

Founded in： 2014

Total resources： 8

E-ISSN： 2212-6988|1|2

ISSN： 2212-697x

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Clinical Cancer Drugs,volume 1,issue 2

Menu

Complex 3D Models to Study Drug Targeting of Invadopodia

Clinical Cancer Drugs,volume 1,issue 2 , Vol. 1, Iss. 2, 2014-05 , pp. 85-89

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Preclinical Models to Study Breast Cancer

Clinical Cancer Drugs,volume 1,issue 2 , Vol. 1, Iss. 2, 2014-05 , pp. 90-99

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Preclinical Bases of the Rational Combination of Paclitaxel and Antiangiogenic Drugs

Clinical Cancer Drugs,volume 1,issue 2 , Vol. 1, Iss. 2, 2014-05 , pp. 100-115

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy

Clinical Cancer Drugs,volume 1,issue 2 , Vol. 1, Iss. 2, 2014-05 , pp. 116-126

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Current Overview on the Usage of Poly(ADP-ribose)polymerase (PARP) Inhibitors in Treating Cancer

Clinical Cancer Drugs,volume 1,issue 2 , Vol. 1, Iss. 2, 2014-05 , pp. 127-148

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Acknowledgements to Reviewers

Clinical Cancer Drugs,volume 1,issue 2 , Vol. 1, Iss. 2, 2014-05 , pp. 149-149

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 6 item(s)